World Gene Therapy Market

Table of Contents

• 1. Executive Summary
  • 1. Executive Summary
    • 1. Executive Summary
• 2. Glossary
  • 1. Glossary
    • 1. Glossary
• 3. Introduction
  • 1. Gene Therapy-An Overview
    • 1. Market Definition
    • 2. Technologies Used in Gene Therapy
• 4. Market Overview
  • 1. Market Challenges
    • 1. Challenges for the Gene Therapy Market
      • a. Lack of Clinical Success
      • b. High Levels of Surveillance and Compliance Expectations from Regulatory Agencies
      • c. Negative Perception and Acceptance of Gene Therapy
      • d. Technical and Safety Issues over Gene Delivery Specificity
      • e. Lack of Standardisation of Clinical Procedures and Manufacturing Methodologies
      • f. High Anticipated Cost of Gene Therapy Products
  • 2. Clinical Research Trends in Gene Therapy
    • 1. Research Trends
    • 2. Clinical Pipeline Analysis
  • 3. Regulatory Affairs
    • 1. Regulatory Affairs in the United States
    • 2. Regulatory Affairs in Europe
• 5. Market Analysis
  • 1. Research Methodology
    • 1. Methodology and Assumptions
  • 2. Market Drivers and Restraints
    • 1. Market Drivers
      • a. Demand for Treatments for Areas of Unmet Medical Need
      • b. Licensing of Key Gene Delivery Patents Generates Market Revenue
      • c. New Technologies Improve Transgene Expression
      • d. Human Genome Project Provides New Leads
    • 2. Market Restraints
      • a. Clinical Failures and Patient Fatalities
      • b. Retraction of Key Industry Participants and Pharmaceutical Giants
      • c. Patient Recruitment Issues in Clinical Trials
      • d. High Cost of Finished Products
  • 3. Market Analysis
    • 1. Market Engineering Measurements
    • 2. Revenue Forecasts
• 6. Competitive Analysis
  • 1. Competitive Structure
    • 1. Competitive Highlights
  • 2. Competitive Analysis
    • 1. Competitors in the Gene Therapy Market-Oncology
    • 2. Competitors in the Gene Therapy Market-Cardiovascular
    • 3. Competitors in the Gene Therapy Market-Monogenic
    • 4. Competitors in the Gene Therapy Market-Enabling Technologies and Generalist Providers
• 7. Strategic Analysis and Recommendations
  • 1. Market Engineering Strategy
    • 1. Strategic Analysis
    • 2. Strategic Priorities
• 8. Frost & Sullivan Awards
  • 1. Frost & Sullivan Award Candidates
    • 1. Introduction to Frost & Sullivan Awards
    • 2. Technology Leadership Award
    • 3. Entrepreneurial Company Award
    • 4. Growth Strategy Leadership Award
• 9. Decision Support Databases
  • 1. Pharmaceutical and Biotechnology Market Metrics
    • 1. Number of Biotechnology Companies
    • 2. Biotechnology Private Investment
    • 3. Government Investment in Biotechnology
    • 4. Total Healthcare Expenditure
  • 2. Disease Prevalence
    • 1. Prevalence of Bladder Cancer
    • 2. Prevalence of Breast Cancer
    • 3. Prevalence of Colon Rectum Cancer
    • 4. Prevalence of Liver Cancer
    • 5. Prevalence of Lung Cancer
    • 6. Prevalence of Prostrate Cancer
    • 7. Prevalence of Stomach Cancer